KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Cash & Equivalents (2016 - 2025)

National Health Investors (NHI) has disclosed Cash & Equivalents for 17 consecutive years, with $19.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 19.21% year-over-year to $19.6 million, compared with a TTM value of $19.6 million through Dec 2025, down 19.21%, and an annual FY2025 reading of $19.6 million, down 19.21% over the prior year.
  • Cash & Equivalents was $19.6 million for Q4 2025 at National Health Investors, down from $24.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $113.4 million in Q1 2021 and bottomed at $13.9 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $31.5 million, with a median of $23.3 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents surged 146.21% in 2021, then tumbled 68.14% in 2022.
  • Year by year, Cash & Equivalents stood at $37.4 million in 2021, then plummeted by 48.44% to $19.3 million in 2022, then increased by 15.84% to $22.3 million in 2023, then rose by 8.69% to $24.3 million in 2024, then dropped by 19.21% to $19.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for NHI at $19.6 million in Q4 2025, $24.3 million in Q4 2024, and $15.6 million in Q3 2024.